BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/13/2023 8:46:32 AM | Browse: 383 | Download: 1478
 |
Received |
|
2023-03-27 14:58 |
|
Peer-Review Started |
|
2023-03-27 15:01 |
|
First Decision by Editorial Office Director |
|
2023-05-18 10:49 |
|
Return for Revision |
|
2023-05-18 10:49 |
|
Revised |
|
2023-06-04 14:32 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-06-29 02:57 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-07-03 15:09 |
|
Articles in Press |
|
2023-07-03 15:09 |
|
Edit the Manuscript by Language Editor |
|
2023-06-19 17:35 |
|
Typeset the Manuscript |
|
2023-07-10 02:03 |
|
Publish the Manuscript Online |
|
2023-07-13 08:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Martina Crepaldi, Daria Maniero, Alessandro Massano, Margherita Pavanato, Brigida Barberio, Edoardo Vincenzo Savarino and Fabiana Zingone |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fabiana Zingone, MD, PhD, Assistant Professor, Doctor, Doctor, Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2
, Padua 35128, Italy. fabiana.zingone@unipd.it |
| Key Words |
Azathioprine; Inflammatory bowel diseases; Ulcerative Colitis; Crohn's Disease; Relapse; Side effects |
| Core Tip |
Prolonged use of azathioprine (AZA) remains controversial, and the time of interruption is uncertain. This retrospective study analyzed our single-center data of patients affected by inflammatory bowel disease who had started and then discontinued AZA between 1995 and 2022. AZA administration was effective and safe, and only 10% of patients who achieved remission with AZA needed a new treatment within 1 year of drug interruption. |
| Publish Date |
2023-07-13 08:46 |
| Citation |
Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F. Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study. World J Gastroenterol 2023; 29(27): 4334-4343 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i27/4334.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i27.4334 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
